Explore 3 Stock Ideas & Industry Insights Download Free Report

General News

Eli Lilly & Company (NYSE: LLY) GLP-1 Windfall Fuels M&A Ambitions

Eli Lilly & Company (NYSE: LLY), the world's largest pharmaceutical company, has announced that it will use the financial windfall from its GLP-1 medications, such as Mounjaro and Zepbound, to fund its aggressive dealmaking strategy. This shift in approach marks a significant departure from …

Vinay Lochav | 03 June 2026

Dollar General Corp (NYSE: DG) Maintained at In-Line by Evercore ISI Group

Dollar General Corp (NYSE: DG) has been maintained at an in-line rating by Evercore ISI Group. This decision suggests the analyst group remains neutral on the retail company's performance.

Vinay Lochav | 03 June 2026

Copa Holdings (NYSE: CPA) Receives Overweight Rating from JP Morgan

Copa Holdings, theParent Companyof Copa Airlines, has received an Overweight rating from JP Morgan, a majorWall StreetInvestmentbank. This assessment reflects the bank's expectations for the company's future prospects.

Vinay Lochav | 03 June 2026

Kalshi reports George Santos to US prosecutors over prediction market bets, AP reports

Key SummaryPrivatePayrollGrowth:ADP reports 122,000 new jobs in May, exceeding the expected 110,000, with the strongest month since January 2025.Sectoral Distribution:The gains were more broad-based, with eight of the 10 sectors tracked by ADP showing increases, while two sectors reported losses.Salary Growth:Annual pay rose 4.4% …

Vinay Lochav | 03 June 2026

Invesco High Income Trust II Announces Portfolio Management Changes (NYSE: VLT)

Invesco High Income Trust II announced portfolio management changes, naming Thomas Moore and Rahim Shad as the joint and primary responsible individuals for the day-to-day management of the fund's portfolio. These changes took effect on June 3, 2026.

Vinay Lochav | 03 June 2026

Fulcrum Therapeutics Inc. (NASDAQ: FULC) Faces Possible Securities Law Violations Amid FDA Safety Concerns

Fulcrum Therapeutics Inc. (Nasdaq: FULC) lost approximately 50% of its value in a single session after disclosing that the FDA had raised class-wide safety concerns about PRC2-targeting agents. This dramatic price drop was triggered by the Company's decision to discontinue its lead candidate pociredir, …

Vinay Lochav | 03 June 2026

Lululemon Athletica Inc. (NASDAQ: LULU) Understood to be In-Line

Lululemon Athletica Inc. (NASDAQ: LULU) has been rated as in-line by the Evercore ISI Group.

Vinay Lochav | 03 June 2026

Lear Corporation (NYSE: LEA) EVP Sells Shares Worth Over $742K

Frank C. Orsini, Executive Vice President and President of Seating at Lear Corporation, sold a significant amount of shares in the company on 2026-06-02. According to publicly available data, Orsini sold 5,000 shares of Common Stock at a price of USD 148.50 per share, …

Vinay Lochav | 03 June 2026